Company profile: Axion Biosystems
1.1 - Company Overview
Company description
- Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
Products and services
- Maestro ZHT: High-throughput platform delivering continuous, label-free, impedance-based monitoring of cell proliferation, death, morphology, attachment, and signaling in 384- and 96-well plate formats
- Maestro Z: Research-grade impedance platform producing real-time, continuous, label-free analysis of cell proliferation, viability, morphology, and immune cell-mediated killing
- Impedance Module: Modular add-on for Maestro systems enabling real-time, label-free tracking of cell proliferation, viability, morphology, and immune cell-mediated killing during impedance assays
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Axion Biosystems
Dyadic
HQ: United States
Website
- Description: Provider of microbial protein production platforms and bio-based chemicals. Offers the C1 Platform for developing and manufacturing vaccines, antibodies, and therapeutic proteins for human and animal health; the Dapibus Platform for rapid, large-scale non-pharmaceutical proteins for food and nutrition; recombinant HSA, alpha-lactalbumin, and transferrin; and the DYAI-100 COVID-19 vaccine candidate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dyadic company profile →
Cellartis
HQ: Sweden
Website
- Description: Provider of biotechnology, based in Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellartis company profile →
NeuMoDx Molecular
HQ: United States
Website
- Description: Provider of molecular diagnostic (MDx) testing solutions for hospital and clinical reference laboratories, including fully automated, continuous random-access analyzers (NeuMoDx 288 and 96) that integrate sample-to-result using proprietary NeuDry reagent technology, plus lysis buffers (3 and 4), an HBV quant test strip, and a GBS assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuMoDx Molecular company profile →
Agilent
HQ: United States
Website
- Description: Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agilent company profile →
AHN Biotechnologie
HQ: Germany
Website
- Description: Provider of plastic laboratory articles for molecular-biological, biochemical, cellbiological and pharmaceutical research, including innovative precision pipette tips, precision filter tips and modern micropipettes, produced in a high-tech manufacturing facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AHN Biotechnologie company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Axion Biosystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Axion Biosystems
2.2 - Growth funds investing in similar companies to Axion Biosystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Axion Biosystems
4.2 - Public trading comparable groups for Axion Biosystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →